Dichotomic effects of clinically used drugs on tumor growth, bone remodeling and pain management.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 12 2019
Historique:
received: 10 04 2019
accepted: 12 12 2019
entrez: 29 12 2019
pubmed: 29 12 2019
medline: 29 12 2019
Statut: epublish

Résumé

Improvements in the survival of breast cancer patients have led to the emergence of bone health and pain management as key aspects of patient's quality of life. Here, we used a female rat MRMT-1 model of breast cancer-induced bone pain to compare the effects of three drugs used clinically morphine, nabilone and zoledronate on tumor progression, bone remodeling and pain relief. We found that chronic morphine reduced the mechanical hypersensitivity induced by the proliferation of the luminal B aggressive breast cancer cells in the tumor-bearing femur and prevented spinal neuronal and astrocyte activation. Using MTT cell viability assay and MRI coupled to

Identifiants

pubmed: 31882872
doi: 10.1038/s41598-019-56622-5
pii: 10.1038/s41598-019-56622-5
pmc: PMC6934511
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20155

Subventions

Organisme : Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada)
ID : 353649
Pays : International

Commentaires et corrections

Type : ErratumIn

Références

J Pain. 2016 Aug;17(8):889-903
pubmed: 27063783
J Biol Chem. 2015 Sep 4;290(36):22049-60
pubmed: 26195631
Front Endocrinol (Lausanne). 2012 Nov 16;3:136
pubmed: 23181053
PLoS One. 2010 Oct 29;5(10):e13774
pubmed: 21048940
BMC Musculoskelet Disord. 2015 Nov 16;16:355
pubmed: 26572124
Pain. 2007 Nov;132(1-2):154-68
pubmed: 17706870
Clin Exp Metastasis. 2013 Feb;30(2):225-36
pubmed: 22956259
Brain Behav Immun. 2016 Nov;58:348-356
pubmed: 27519154
Pharmacotherapy. 2016 Mar;36(3):273-86
pubmed: 26923810
Eur J Pain. 2008 Apr;12(3):284-92
pubmed: 17664076
J Craniomaxillofac Surg. 2018 Apr;46(4):538-546
pubmed: 29454604
Pain Pract. 2011 Jul-Aug;11(4):353-68
pubmed: 21087411
J Neurosci. 2007 May 30;27(22):6006-18
pubmed: 17537972
Biomed Res Int. 2013;2013:258141
pubmed: 24069592
Life Sci. 2010 Apr 24;86(17-18):646-53
pubmed: 20176037
Eur J Pain. 2018 Mar;22(3):455-470
pubmed: 29034533
Brain Res. 2008 Jun 18;1215:69-75
pubmed: 18486111
J Pain. 2008 Feb;9(2):164-73
pubmed: 17974490
Pathology. 2017 Feb;49(2):111-119
pubmed: 28040199
J Cell Biochem. 1994 Jul;55(3):334-9
pubmed: 7962165
Neuropsychopharmacology. 2017 Aug;42(9):1752-1765
pubmed: 28327548
Ann Oncol. 2013 Sep;24(9):2206-23
pubmed: 23917950
J Intern Med. 2006 Jul;260(1):76-87
pubmed: 16789982
Anesth Analg. 2017 Nov;125(5):1638-1652
pubmed: 28537982
RNA. 2010 Feb;16(2):442-9
pubmed: 20038630
Bonekey Rep. 2013 Feb 06;2:267
pubmed: 24422040
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:259-66
pubmed: 26071989
Brain Behav Immun. 2010 Jan;24(1):83-95
pubmed: 19679181
J Bone Oncol. 2014 Jan 15;3(1):25-35
pubmed: 26909294
J Interferon Cytokine Res. 2015 Jan;35(1):1-16
pubmed: 25068787
Pharmacology. 2013;92(3-4):150-7
pubmed: 24008428
Pain. 2018 Sep;159(9):1814-1823
pubmed: 29781960
Mediators Inflamm. 2015;2015:984570
pubmed: 26538839
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):696-701
pubmed: 16407142
Pain. 2002 Oct;99(3):397-406
pubmed: 12406514
Neuron Glia Biol. 2006 Nov;2(4):259-69
pubmed: 17710215
Breast Cancer (Dove Med Press). 2011 May 02;3:35-60
pubmed: 24367175
Breast. 2018 Feb;37:28-35
pubmed: 29073497
Drug Alcohol Rev. 2011 Nov;30(6):577-82
pubmed: 21355904
Behav Pharmacol. 2011 Sep;22(5-6):607-16
pubmed: 21610490
Eur J Intern Med. 2018 Mar;49:30-36
pubmed: 29482740
Pain. 2004 Sep;111(1-2):169-80
pubmed: 15327821
Pain Med. 2000 Dec;1(4):303-9
pubmed: 15101876
Lancet Oncol. 2008 Sep;9(9):840-9
pubmed: 18718815
J Immunol. 2003 Apr 1;170(7):3688-95
pubmed: 12646634
J Bone Miner Res. 2013 Jan;28(1):92-107
pubmed: 22903605
J Natl Compr Canc Netw. 2015 Apr;13(4):480-6
pubmed: 25870382
Cancer Metastasis Rev. 2011 Jun;30(2):225-38
pubmed: 21267766
BMC Res Notes. 2012 Jul 25;5:376
pubmed: 22830453
Acta Pathol Jpn. 1975 Jul;25(4):451-61
pubmed: 170787
Eur J Pharmacol. 1997 Sep 24;335(2-3):255-65
pubmed: 9369381
Br J Pharmacol. 2010 Jun;160(3):561-73
pubmed: 20233215
Cancer. 1997 Oct 15;80(8 Suppl):1588-94
pubmed: 9362426
BMJ. 2008 Jan 26;336(7637):199-201
pubmed: 18182416
Mol Cancer Ther. 2009 Nov;8(11):3117-29
pubmed: 19887554
Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6243s-6249s
pubmed: 17062708
Mol Med Rep. 2016 Jan;13(1):613-22
pubmed: 26648136
Pain. 2003 Jan;101(1-2):175-86
pubmed: 12507712
Pain. 2013 Jun;154(6):917-26
pubmed: 23582155
J Am Geriatr Soc. 2011 Mar;59(3):430-8
pubmed: 21391934
Clin Transl Oncol. 2018 Jul;20(7):808-814
pubmed: 29127594
J Pain. 2005 Dec;6(12):837-45
pubmed: 16326372
Semin Cell Dev Biol. 2017 Apr;64:65-72
pubmed: 27569190
Pain. 2012 Oct;153(10):2073-82
pubmed: 22921260
Cancer Res. 1990 Apr 15;50(8):2234-8
pubmed: 2156613
Curr Opin Support Palliat Care. 2014 Dec;8(4):420-8
pubmed: 25121618
J Support Oncol. 2008 Mar;6(3):119-24
pubmed: 18402303
J Nucl Med. 2013 Jun;54(6):944-52
pubmed: 23596003
Addiction. 2011 Feb;106(2):349-54
pubmed: 20955216
J Basic Clin Physiol Pharmacol. 2016 May 1;27(3):237-45
pubmed: 26457774
Pharmacol Res. 2017 May;119:391-403
pubmed: 28274851
Br J Pharmacol. 2015 Jan;172(2):251-9
pubmed: 24467261
Eur J Pain. 2018 Mar;22(3):471-484
pubmed: 29160600
Neuroendocrinology. 2000 Sep;72(3):187-94
pubmed: 11025413
Clin Med Insights Oncol. 2014 Sep 11;8:107-11
pubmed: 25249766
Neuroscience. 2000;98(3):585-98
pubmed: 10869852
J Clin Pharmacol. 2002 Nov;42(11):1228-36
pubmed: 12412821
Am J Clin Pathol. 2015 Apr;143(4):471-8
pubmed: 25779997
Cancer Treat Rev. 2012 Nov;38(7):911-8
pubmed: 22776349
Lancet Oncol. 2010 May;11(5):484-9
pubmed: 20434717
Br J Pharmacol. 2011 Aug;163(7):1447-63
pubmed: 21410463
Ann Oncol. 2013 Feb;24(2):398-405
pubmed: 23047045
Sci Rep. 2017 Mar 27;7:45411
pubmed: 28345619
J Drug Target. 2015 Jan;23(1):1-15
pubmed: 25203856
Curr Drug Saf. 2011 Jul;6(3):159-63
pubmed: 22122391
J Clin Oncol. 2003 Nov 1;21(21):4042-57
pubmed: 12963702
J Gen Intern Med. 2010 Apr;25(4):310-5
pubmed: 20049546

Auteurs

David André Barrière (DA)

Département de Pharmacologie-Physiologie/Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Québec, Canada.

Élora Midavaine (É)

Département de Pharmacologie-Physiologie/Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Québec, Canada.

Louis Doré-Savard (L)

Département de Pharmacologie-Physiologie/Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Québec, Canada.

Karyn Kirby (K)

Département de Pharmacologie-Physiologie/Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Québec, Canada.

Luc Tremblay (L)

Département de médecine nucléaire et de radiobiologie, Université de Sherbrooke et Centre d'imagerie moléculaire de Sherbrooke, Sherbrooke, Québec, Canada.

Jean-François Beaudoin (JF)

Département de médecine nucléaire et de radiobiologie, Université de Sherbrooke et Centre d'imagerie moléculaire de Sherbrooke, Sherbrooke, Québec, Canada.

Nicolas Beaudet (N)

Département d'Anesthésiologie, Université de Sherbrooke, Québec, Canada.

Jean-Michel Longpré (JM)

Département de Pharmacologie-Physiologie/Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Québec, Canada.

Roger Lecomte (R)

Département de médecine nucléaire et de radiobiologie, Université de Sherbrooke et Centre d'imagerie moléculaire de Sherbrooke, Sherbrooke, Québec, Canada.

Martin Lepage (M)

Département de médecine nucléaire et de radiobiologie, Université de Sherbrooke et Centre d'imagerie moléculaire de Sherbrooke, Sherbrooke, Québec, Canada.

Philippe Sarret (P)

Département de Pharmacologie-Physiologie/Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Québec, Canada. philippe.sarret@usherbrooke.ca.

Classifications MeSH